11 September 2024 - NICE has published final evidence-based recommendations on the use of faricimab (Vabysmo) for the treatment of adults with visual impairment caused by macular oedema after retinal vein occlusion.

Faricimab is recommended as an option for the treatment of adults with visual impairment caused by macular oedema after central or branch retinal vein occlusion. It is only recommended if Roche provides it according to the commercial arrangement.

Read NICE technology appraisal guidance